[1]
Goud, T.E., Maddi, S., Devanna, N. and Prasad, T.R. 2016. Evaluation of pharmacokinetic and pharmacodynamic interaction between repaglinide and atazanavir in healthy, diabetic and hepatic impaired rats: possible inhibition of CYP3A, OATP, and P-glycoprotein transporters. ADMET and DMPK. 4, 3 (Oct. 2016), 269–279. DOI:https://doi.org/10.5599/admet.4.3.328.